BASIC RESEARCH
Effects of 744ins20 – ter240 BRCA1 mutation on breast/ovarian carcinogenesis and the role of curcumin in telomerase inhibition
 
More details
Hide details
 
Submission date: 2017-07-16
 
 
Final revision date: 2017-09-01
 
 
Acceptance date: 2017-09-01
 
 
Publication date: 2017-10-12
 
 
Arch Med Sci Civil Dis 2017;2(1):125-129
 
KEYWORDS
TOPICS
ABSTRACT
Introduction: Breast cancer is cancer which develops from breast tissue. It can also begin in the cells of the lobules and in other tissues in the breast. Invasive breast cancer is breast cancer that has spread from where it began in the ducts or lobules to surrounding tissue. Breast cancer risk is correlated with high estrogen level. BRCA1 gene mutation increases the risk of hereditary breast/ovarian carcinogenesis. Telomerase can protect telomere shortening. It plays a key role in cancer development. Curcumin is a yellow component in Curcuma longa Linn. and has antioxidant properties. It has a potential role in inhibition of cellular migration or invasion and even metastasis.
Material and methods: A study on the effect of 744ins20 – ter240 BRCA1 mutation at exon 10 on DNA repair function by MTT dye reduction and a study on telomerase inhibition caused by curcumin with the telomerase activity assay and trypan blue exclusion assay were conducted.
Results: The percentages of cell viability in mutant cells were lower than the percentages of cell viability in wild type cells at various H2O2 concentrations (p < 0.05). This mutation caused a DNA repair defect and curcumin could inhibit telomerase function and affected cancer cell progression.
Conclusions: 744ins20 – ter240 BRCA1 mutation is involved in a DNA repair defect. It drives oxidative stress. Cancer development prevention by enhancing antioxidant defenses may be affected by this mutation, and it causes breast/ovarian carcinogenesis. Curcumin can inhibit telomerase function. Antioxidants need to be explored for the prophylaxis and treatment of hereditary and basal-like breast cancers.
 
REFERENCES (17)
1.
Rosen EM, Fan S, Pestell RG, Goldberg ID. The BRCA1 gene in breast cancer. J Cell Physiol 2003; 196: 19-41.
 
2.
Rakha EA, El-Sheikh SE, Kandil MA, El-Sayed ME, Green AR, Ellis IO. Expression of BRCA1 protein in breast cancer and its prognosis significance. Hum Pathol 2008; 39: 857-65.
 
3.
Lin JK, Lin-Shiau SY. Mechanisms of cancer chemoprevention by curcumin. Proc Natl Sci Counc Repub China B 2001; 25: 59-66.
 
4.
Jiang S, Han J, Li T, et al. Curcumin as a potential protective compound against cardiac diseases. Pharmacol Res 2017; 119: 373-83.
 
5.
Smogorzewska A, De Lang T. Regulation of telomerase by telomeric protein. Annu Rev Biochem 2004; 73: 177-208.
 
6.
Patmasiriwat P, Bhothisuwan K, Sinilnikova OM, et al. Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early- onset breast and ovarian cancer. Human Mutat 2002; 20: 230.
 
7.
Toullec A, Gerald D, Despouy G, et al. Oxidative stress promotes myofibroblast differentiation and tumor spreading. EMBO Mol Med 2010; 2: 211-30.
 
8.
Scully R, Chen J, Ochs RL, et al. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 1997; 90: 425-35.
 
9.
MacLachlan TK, Somasundaram K, Sgagias M, et al. BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression. J Biol Chem 2000; 275: 2777-85.
 
10.
Xiong J, Fan S, Meng Q, et al. BRCA1 inhibition of telomerase activity in cultured cells. Mol Cell Biol 2003; 23: 8668-90.
 
11.
Yarden RI, Brody LC. BRCA1 interacts with components of the histone deacetylase complex. Proc Natl Acad Sci USA 1998; 96: 4983-8.
 
12.
Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, Qin J. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 2000; 14: 927-39.
 
13.
Fan S, Yuan RQ, Ma YX, Meng Q, Goldberg ID, Rosen EM. Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1. Oncogene 2001; 20: 8215-35.
 
14.
Chen A, Xu J, Johnson AC. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene 2006; 25: 278-87.
 
15.
Weir NM, Selvendiran K, Kutala VK, et al. Curcumin induces G2/M arrest and apoptosis in cisplatin – resistant human ovarian cancer cells by modulating Akt and p38 MAPK. Cancer Biol Ther 2007; 6: 174-84.
 
16.
Shay JW, Wright WE. Role of telomeres and telomerase in cancer. Semin Cancer Biol 2011; 21: 349-53.
 
17.
Shay JW, Zou Y, Hiyama E, Wright WE. Telomerase and cancer. Hum Mol Genet 2001; 10: 677-85.
 
ISSN:2451-0637
Journals System - logo
Scroll to top